doxorubicin

FDA approves doxorubicin, an anti - tumor antibiotic from Streptomyces bacteria.

1974年, FDA批準一種來源于鏈球菌的抗腫瘤抗生素-阿霉素.

互聯網

Verapamil partially reversed the resistance of MCF - 7 Adr to doxorubicin.

維拉帕米可逆轉MCF - 7Adr對阿霉素的抗藥性.

互聯網

The adsorption behavior of chemotherapy doxorubicin on magnetic nanoparticles was studied.

研究化療藥物阿霉素在磁性納米微球表面的吸脫附行為.

互聯網

OBJECTIVE To prepare doxorubicin loaded octyl - N'- succinyl chitosan micelles and study the in vitro anti - tumor activity .

目的制備阿霉素高聚物膠束并研究其體外 抗腫瘤活性.

互聯網

Results AOT - alginate nanoparticles demonstrated sustained release of doxorubicin oer a 15 - day period in vitro.

結果:體外15天以上的試驗顯示AOT - 藻酸鹽納米粒對阿霉素有緩釋作用.

互聯網

Objective To probe the nursing method, abate the local side reaction of chemotherapy with doxorubicin.

目的探討減輕蒽環類化療藥物在治療過程中所致局部不良反應的護理方法.

互聯網

This translates into enhanced therapeutic efficacy for drugs like doxorubicin that hae intracellular site of action.

繼而又轉化成提高阿霉素這類作用于細胞內位點藥物的治療效果.

互聯網

The authors investigated the postoperative antiscarring effects of topically applied doxorubicin ( DXR ) on rat sciatic nerves.

作者研究了對大鼠坐骨神經術中局部應用多柔比星 ( DXR ),術后DXR的抗瘢痕效果.

互聯網